YANGZHOU, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Meihua International Medical Technologies Co., Ltd. (“Meihua” or the “Company”) (Nasdaq: MHUA), reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that it would effectuate a reverse share split of its outstanding ordinary shares, par value of $0.0005 per share, at a ratio of 1-for-100, and implement its dual-class share structure, to be effective at the open of business on Mo ...

Core Points - LXP Industrial Trust completed a reverse split of its common shares at a ratio of 1-for-5, effective after the close of business on November 10, 2025 [1][2] - The number of outstanding common shares was reduced from approximately 295.8 million to approximately 59.2 million shares, with no significant impact on shareholders' ownership percentages [2] - Trading of LXP's common shares on a split-adjusted basis will commence on November 11, 2025, under the same NYSE symbol "LXP" but with a new CUSIP number [3] - The quarterly dividend will increase from $0.14 to $0.70 per share after the reverse share split, applicable for shareholders of record as of December 31, 2025 [3] Company Overview - LXP Industrial Trust is a publicly traded real estate investment trust (REIT) focused on Class A warehouse and distribution investments across 12 target markets in the Sunbelt and lower Midwest [5] - The company aims to expand its portfolio through various strategies, including acquisitions, build-to-suit transactions, sale-leaseback transactions, and development projects [5]

Core Points - NLS Pharmaceutics Ltd. plans to execute a reverse share split at a ratio of 1-for-10, effective on October 30, 2025, in conjunction with a merger with Kadimastem Ltd. [1][2] - Following the reverse split, the company's common shares will trade under the new symbol "NCEL" starting October 31, 2025 [1][2] - The reverse split will also apply to preferred shares and preferred participation certificates at the same 1-for-10 ratio [3] Company Structure Post-Merger - After the reverse split and merger, the company's registered capital will consist of CHF 282,908.80, divided into 5,533,183 common shares and 124,993 preferred shares, among other capital structures [4] - The total outstanding common shares will be 4,558,378, with additional shares issuable upon the exercise of pre-funded warrants [6] Shareholder Impact - No fractional shares will be issued; instead, cash will be provided for any fractional shares resulting from the reverse split [5] - The reverse split will not affect shareholders' percentage ownership or voting power, aside from minor adjustments due to fractional shares [5]

Core Points - Fusion Fuel Green PLC announced a 1-for-35 reverse share split of its Class A Ordinary Shares to regain compliance with Nasdaq's minimum bid price requirement [3][4] - The reverse share split will take effect on July 14, 2025, with the new CUSIP number being G3R25D 209 [2] - Following the reverse share split, the number of issued and outstanding Class A Ordinary Shares will decrease from approximately 27,418,159 to approximately 783,376 [5] Company Actions - The board of directors approved the reverse share split on June 25, 2025, during the Annual General Meeting [4] - Shareholders also approved an increase in the Company's authorized share capital to ensure 100,000,000 authorized Class A Ordinary Shares post-split [4][5] - The nominal value of each Class A Ordinary Share will be adjusted to $0.0035 as a result of the reverse share split [5] Shareholder Information - No fractional shares will be issued; any resulting fractional shares will be rounded up to the nearest whole share [6] - Registered shareholders will not need to take action to receive their post-split shares, and those holding shares electronically will see the changes reflected automatically [6] Company Overview - Fusion Fuel Green PLC is an energy company providing engineering, advisory, and fuel distribution solutions, actively expanding into new sectors and geographies [8]

Core Points - Fusion Fuel Green PLC announced a 1-for-35 reverse share split to regain compliance with Nasdaq's minimum bid price requirement [3][5] - The reverse share split will reduce the number of issued and outstanding Class A Ordinary Shares from approximately 27,418,159 to approximately 783,376 [5] - The new nominal value of each Class A Ordinary Share will be adjusted to $0.0035 following the reverse share split [5] Company Actions - The reverse share split was approved by the board of directors on June 25, 2025, during the Annual General Meeting [4] - Shareholders also approved an increase in the Company's authorized share capital to ensure 100,000,000 authorized Class A Ordinary Shares post-split [4][5] - The reverse share split will not result in fractional shares; any resulting fractional shares will be rounded up to the nearest whole share [6] Trading Information - The Class A Ordinary Shares will continue to trade on Nasdaq under the symbol "HTOO" and will begin trading on a split-adjusted basis on July 14, 2025 [2] - The new CUSIP number for the Class A Ordinary Shares after the reverse share split will be G3R25D 209 [2]

Core Viewpoint - Jeffs' Brands Ltd plans to implement a one-for-seventeen reverse share split, reducing the number of outstanding shares from approximately 9.4 million to about 553,385, effective June 16, 2025 [1][3]. Group 1: Reverse Share Split Details - The reverse share split was approved by shareholders on April 28, 2025, and will be executed at the board's discretion [2]. - The reverse split will not change the authorized share capital, which remains at 1.5 billion ordinary shares [2]. - All shareholders will be affected uniformly, with no change to their percentage ownership, except for minor adjustments related to fractional shares [3]. Group 2: Shareholder Impact - The number of issued and outstanding ordinary shares will decrease significantly, from 9,407,534 to approximately 553,385 [3]. - Fractional shares will not be issued; instead, they will be rounded to the nearest whole share at the DTC participant level [3]. - Adjustments will be made to the exercise price and the number of shares for all outstanding options and warrants, with similar rounding for fractional shares [3]. Group 3: Company Overview - Jeffs' Brands is focused on transforming e-commerce by creating and acquiring products to become market leaders, leveraging insights into the Amazon FBA business model [4].

Core Viewpoint - Jeffs' Brands Ltd plans to implement a one-for-seventeen reverse share split, reducing the number of outstanding shares from approximately 9.4 million to about 553,385, effective June 16, 2025 [1][3]. Group 1: Reverse Share Split Details - The reverse share split was approved by shareholders on April 28, 2025, and will be executed at the board's discretion [2]. - The reverse split will not change the authorized share capital, which remains at 1.5 billion ordinary shares [2]. - All shareholders will be affected uniformly, with no change to their percentage ownership, except for minor adjustments related to fractional shares [3]. Group 2: Shareholder Impact - The number of issued and outstanding ordinary shares will decrease significantly, and fractional shares will be rounded to the nearest whole share [3]. - Adjustments will be made to the exercise price and the number of shares for all outstanding options and warrants, with no fractional shares issued upon exercise [3]. Group 3: Company Overview - Jeffs' Brands is focused on transforming e-commerce by creating and acquiring products, leveraging insights into the Amazon FBA business model [4].

Core Viewpoint - Freight Technologies, Inc. has announced a one-for-four reverse share split of its ordinary shares, effective May 27, 2025, aimed at consolidating its share structure and potentially enhancing its stock price [1][2]. Share Structure Changes - The reverse split will reduce the number of outstanding ordinary shares from 9,145,074 to 2,286,269, with every four pre-split shares combining into one post-split share [2][4]. - The shares will continue to trade on the Nasdaq under the symbol "FRGT" but will have a new CUSIP number: G51413147 [2][4]. Fractional Shares Handling - No fractional shares will be issued; shareholders entitled to a fractional share will receive an additional share to round up to the next whole share if the fractional share is less than one-half [3]. - Fractional shares equal to less than one-half will be canceled [3]. Company Overview - Freight Technologies, Inc. specializes in logistics management and offers a range of technology-driven solutions, including the Fr8App platform for cross-border shipping, Fr8Now for less-than-truckload shipping, and other services aimed at optimizing supply chain processes [5]. - The company utilizes AI and machine learning to enhance operational efficiency and improve the matching of carriers and shippers [5].

Core Points - Sol-Gel Technologies Ltd. announced a 10-for-1 reverse share split to increase the per share market price and regain compliance with Nasdaq's minimum bid price requirement [4][5][6] Group 1: Reverse Share Split Details - The reverse share split will consolidate every ten ordinary shares into one ordinary share, effective at 11:59 p.m. Eastern Time on May 2, 2025 [3][5] - The first trading day on Nasdaq under the new share structure is expected to be May 5, 2025, with the symbol "SLGL" remaining unchanged [3][4] - The par value of the ordinary shares will increase from NIS 0.1 to NIS 1.0, and the total share capital will adjust from 50 million to 5 million ordinary shares [6] Group 2: Shareholder Approval and Process - Shareholders approved the reverse split ratio at a special meeting on April 1, 2025, with the board of directors confirming the 10-for-1 ratio on April 9, 2025 [2] - Equiniti Trust Company, LLC will act as the exchange and transfer agent for the reverse split, and shareholders holding shares electronically will not need to take action to receive post-split shares [7] Group 3: Company Overview - Sol-Gel Technologies is focused on developing and commercializing drug products for skin diseases, with FDA-approved products including TWYNEO for acne and EPSOLAY for rosacea [8] - The company's pipeline includes SGT-610, an orphan drug candidate for Gorlin syndrome, and SGT-210, a topical drug candidate for rare skin keratodermas [9]